Parry, Romani, Deconcini & Symms on Behalf of Fagron
A government relations firm.
Based in DC
🤖
AI Overview
With $0 in lobbying spend across 5 quarterly filings, Parry, Romani, Deconcini & Symms on Behalf of Fagron is an active lobbying client. Their lobbying covers 3 issue areas.
$0
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Pharmacy
- •Legislation and agency guidance documents that impact the operations of pharmacy compounding and access to compounded medications.
- •Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act (503B)) is in alignment with the statutory language. Legislative efforts include working
- •Working to ensure the implementation of the Drug Quality and Security Act (DQSA) (Food, Drug, and Cosmetic Act 503B) is in alignment with the statutory language. Legislative efforts include working on
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Association of Benefits and Insurance Professionals
$8.6M total spend
F Hoffmann-la Roche LTD and its Affiliates
$4.0M total spend
Protecting Access to Pain Relief Coalition
$2.9M total spend
Biotechnology Industry Organization
$2.8M total spend
The Campaign for Sustainable Rx Pricing
$2.6M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.